Paradoxical Effects of NF-kB in Ischemia; Novel Polymeric Gene Silencing in vivo

NF-kB 在缺血中的矛盾作用；

• 批准号: 7882702
• 负责人: Walter Keith Jones
• 金额: $ 62.77万
• 依托单位: UNIVERSITY OF CINCINNATI
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-07-15 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7882702
• 关键词: Acute; Address; Adverse effects; Affect; Basic Science; Binding Proteins; Binding Sites; Biological; Candidate Disease Gene; Cardiac; Cardiac Myocytes; Cardiovascular Diseases; Cardiovascular system; Cell Death; Cell Death Process; Cell Survival; Cessation of life; Chronic; Clinical; Clinical Data; Co-Immunoprecipitations; Complex; Computer Simulation; Coronary; Coronary Occlusions; DNA; DNA Binding; DNA delivery; Development; Dilatation - action; Disease; Disease Progression; Dose; Drug or chemical Tissue Distribution; Evaluation; Functional disorder; Future; Gadolinium; Gene Expression; Gene Expression Regulation; Gene Silencing; Genes; Genetic; Goals; Government; Heart; Heart Diseases; Heart failure; Hypoxia; In Vitro; Individual; Infarction; Injury; Interdisciplinary Study; Ischemia; Knowledge; Laboratories; Lead; Learning; Left; Left Ventricular Remodeling; Link; Magnetic Resonance Imaging; Measurement; Mediating; Modeling; Molecular; Molecular Profiling; Morbidity - disease rate; Mus; Myocardial; Myocardial Infarction; Myocardial Ischemia; Myocardium; NF-kappa B; Necrosis; Nucleic Acids; Outcome; Patients; Persons; Play; Polymers; Process; Reagent; Regulation; Reperfusion Injury; Reperfusion Therapy; Repression; Research; Role; Safety; Signal Transduction; Small Interfering RNA; Stimulus; Techniques; Technology; Testing; Therapeutic; Therapeutic Effect; Therapeutic Uses; Transgenic Mice; Translations; Tweens; United States National Institutes of Health; Unstable angina; Ventricular Function; Ventricular Remodeling; Viral; Work; base; chromatin immunoprecipitation; clinically relevant; cytokine; efficacy testing; implantation; in vivo; in vivo Model; innovation; innovative technologies; mortality; mouse model; new technology; new therapeutic target; novel; novel therapeutics; pre-clinical; preclinical study; prevent; programs; promoter; public health relevance; response; therapeutic target; therapy development; transcription factor; ventricular assist device; ventricular hypertrophy; viral DNA

DESCRIPTION (provided by applicant): Though the role of genes in heart disease is appreciated, there is currently little understanding of the mechanism by which the transcription factor NF-kB contributes to the antithetical processes of cardioprotection and ischemia/reperfusion (I/R) injury. This Critical Gap In Knowledge prevents the successful development of therapies employing NF-kB inhibition or cytokine blockade in cardiovascular disease. The objective of the proposal is to fill this knowledge gap; to develop a comprehensive understanding of the mechanism by which NF-kB and NF-kB-dependent gene expression networks affect I/R injury, cardioprotection, post-I/R dysfunction and heart failure. We offer the central hypothesis that NF-kB mediates differential responses to different stimuli by regulating distinct sets of NF-kB-dependent genes. We propose three specific aims; 1) Delineate the sets of NF-kB-dependent genes that underlie the antithetical effects of NF-kB upon cell death after I/R and PO, 2) Determine the transcriptional mechanism by which NF-kB modulates gene expression to evoke cell death after I/R and cell survival after PO, 3) Determine the biological effects and therapeutic potential of PGAA polyplexes during acute and chronic post-ischemic disease in vivo. The approach is to employ an hypothesis-driven microarray strategy that takes advantage of our IkBDN mice (block NF-kB) to delineate NF-kB-dependent genes functionally associated with NF-kB-dependent pro-injury and cardioprotective effects. We will also employ an innovative non-viral polymeric nucleic acid delivery technology (PGAA) to block NF-kB activation (decoys) and to silence NF-kB-dependent genes (siRNA) in vivo. We expect that the results will provide a mechanistic understanding of how NF-kB-dependent genes underlie differential responses in the heart. Public Health Relevance: The proposed research is significant because it will lead to identification of new therapeutic targets and development of novel therapies for ischemic heart disease. The proposal develops a novel and innovative set of reagents for basic science that can be used for DNA and siRNA delivery in vivo. The proposal is highly translational in that it develops the therapeutic use of PGAA-mediated decoy and siRNA delivery in pre- clinical studies.

描述（由申请人提供）：尽管基因在心脏病中的作用已被认识，但目前对转录因子NF-κ B促进心脏保护和缺血/再灌注（I/R）损伤的对立过程的机制了解甚少。这一关键的知识差距阻碍了在心血管疾病中采用NF-κ B抑制或细胞因子阻断的疗法的成功开发。该提案的目的是填补这一知识空白;全面了解NF-κ B和NF-κ B依赖性基因表达网络影响I/R损伤，心脏保护，I/R后功能障碍和心力衰竭的机制。我们提供的核心假设，NF-κ B介导不同的反应，不同的刺激，通过调节不同的NF-κ B依赖基因。我们提出三个具体目标; 1）描述NF-κ B依赖性基因的集合，所述NF-κ B依赖性基因的集合是NF-κ B对I/R和PO后的细胞死亡的对立作用的基础，2）确定NF-κ B调节基因表达以引起I/R后的细胞死亡和PO后的细胞存活的转录机制，3）确定PGAA复合物在体内急性和慢性缺血后疾病期间的生物学效应和治疗潜力。该方法是采用假设驱动的微阵列策略，该策略利用我们的IkBDN小鼠（阻断NF-κ B）来描绘与NF-κ B依赖性促损伤和心脏保护作用功能相关的NF-κ B依赖性基因。我们还将采用创新的非病毒聚合核酸递送技术（PGAA）来阻断NF-kB激活（诱饵）和沉默NF-kB依赖基因（siRNA）。我们期望这些结果将提供一个机制的理解NF-κ B依赖基因如何在心脏中的差异反应。公共卫生相关性：这项研究具有重要意义，因为它将导致缺血性心脏病新治疗靶点的确定和新疗法的开发。该提案为基础科学开发了一套新颖和创新的试剂，可用于体内DNA和siRNA递送。该提议是高度转化的，因为它开发了PGAA介导的诱饵和siRNA递送在临床前研究中的治疗用途。